Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
for
Solid Tumors
Location: Phoenix AZ, Irving TX, Houston TX, Rochester MN,
Sponsor: Fortvita Biologics (USA)Inc.
Sex: All
Age: 18 - 70+
Code: NCT06963281
Phase 1, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Phoenix AZ, Kingman AZ, Henderson NV, Las Vegas NV,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
for
Acquired Factor X Deficiency
Location: Phoenix AZ, Rochester MN
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18 - 70
Code: NCT06963216
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Phoenix AZ, Orange CA, Los Angeles CA, Amarillo TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Phoenix AZ, St Louis MO, Rochester MN, Jacksonville FL,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT07450859
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
for
Glioblastoma (GBM)
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Myosin Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07185880
Phase 1, Phase 2, Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Phoenix AZ, Tucson AZ, Orange CA, Los Angeles CA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00358943
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Phoenix AZ, Tucson AZ, Chula Vista CA, Tustin CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase 2, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Phoenix AZ, La Jolla CA, Duarte CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Phoenix AZ, Tucson AZ, Irvine CA, Orange CA, Duarte CA,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Phoenix AZ, Santa Monica CA, San Antonio TX, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Orange CA, Santa Fe NM,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Phoenix AZ, Salt Lake City UT, Aurora CO,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase 3, Recruiting
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Phoenix AZ, St. George UT, Las Cruces NM, Cedar City UT,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase 2, Recruiting
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
for
Solid Tumors
Location: Phoenix AZ, Santa Monica CA, Palo Alto CA, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06179160
Phase 1, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Phoenix AZ, La Jolla CA, Irvine CA, Stanford CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase 1, Phase 2, Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Phoenix AZ, Tucson AZ, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase 2, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Phoenix AZ, Tucson AZ, Murrieta CA, Orange CA,